ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1279 • ACR Convergence 2022

    Development of ACR Longitudinal Digital Quality Measures for Systemic Lupus Erythematosus: A Literature Review and Modified Delphi Consensus Study

    Christie Bartels1, April Jorge2, Candace Feldman3, Claire Barber4, April Barnado5, Bonnie Bermas6, Ali Duarte-Garcia7, Shivani Garg8, Leah Haseley9, Shraddha Jatwani10, Tracy Johansson11, Alex Limanni12, Wendy Rodgers13, Brad Rovin14, Yesenia Santiago-Casas15, Lisa Suter16, Jennifer Ude11, JoAnn Zell17 and Jinoos Yazdany18, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Massachusetts General Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4University of Calgary, Calgary, AB, Canada, 5Vanderbilt University Medical Center, Nashville, TN, 6UT Southwestern, Dallas, TX, 7Mayo Clinic, Rochester, MN, 8University of Madison, School of Medicine and Public Health, Madison, WI, 9University of Washington, Harborview Medical Center, Seattle, WA, 10Albert Einstein Medical Center, Ambler, PA, 11American College of Rheumatology, Atlanta, GA, 12Self, Dallas, TX, 13Lupus Foundation of America, Torrance, CA, 14The Ohio State University, Columbus, OH, 15Integral Rheumatology and Immunology Specialists, Plantation, FL, 16Yale School of Medicine, New Haven, CT, 17University of Colorado Anschutz Medical Campus, Denver, CO, 18UCSF, San Francisco, CA

    Background/Purpose: Significant morbidity and mortality urge efforts to improve quality of care for people with systemic lupus erythematosus (SLE). Yet, none of the 25 American…
  • Abstract Number: 1291 • ACR Convergence 2022

    Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth

    david leverenz1, Mary Solomon1, Nicoleta Economau-Zavlanos1, Bhargav Srinivas Adagarla2, Theresa Coles1, Isaac Smith3, Robert Overton1, Catherine Howe3, Jayanth Doss4, Ricardo Henao1 and Megan Clowse4, 1Duke University School of Medicine, Durham, NC, 2Duke Clinical Research Institute, Durham, NC, 3Duke University Hospital, Durham, NC, 4Duke University, Durham, NC

    Background/Purpose: Since January 2021, providers in our practice have used the Encounter Appropriateness Score for You (EASY) to document their perception of the appropriateness of…
  • Abstract Number: 1292 • ACR Convergence 2022

    Telemedicine’s Impact on Radiologic Ordering in an Academic Rheumatology Practice During the COVID-19 Pandemic

    Ben Kellogg, Robert French, Emily Vinson, Erin McCrum and david leverenz, Duke University School of Medicine, Durham, NC

    Background/Purpose: The COVID-19 pandemic necessitated the rapid implementation of telemedicine, and this shift's impact on practice patterns is still being characterized. We theorized that telemedicine…
  • Abstract Number: 1282 • ACR Convergence 2022

    Practice Patterns for Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Among Nephrologists and Rheumatologists – an International Survey Study

    Swati Arora1, Brad Rovin2 and Tanmayee Bichile3, 1Allegheny Health Network, Pittsburgh, 2The Ohio State University, Columbus, OH, 3Allegheny Health Network, Gibsonia, PA

    Background/Purpose: Patients with autoimmune disorders such as systemic lupus erythematosus (SLE), lupus nephritis (LN) and granulomatosis with polyangiitis (GPA) frequently require treatment with immunosuppressive drugs.…
  • Abstract Number: 1290 • ACR Convergence 2022

    Inflammation Is More Prominent Than Joint Damage at Initial Visits of Patients with Inflammatory Arthritides, but Organ Damage and Patient Distress Are as Prominent in Overall Rheumatology Care: Data from a Feasible Physician RheuMetric Checklist

    Juan Schmukler1, Tengfei Li2, Joel Block1 and Theodore Pincus1, 1Rush University Medical Center, Chicago, IL, 2Georgetown University, Washington, DC

    Background/Purpose: Most widely-used rheumatology indices, e.g., DAS28, CDAI, SLEDAI, ASDAS, DAPSA, reflect the mission of rheumatologists to control inflammatory activity (INF) to prevent subsequent organ…
  • Abstract Number: 1303 • ACR Convergence 2022

    Planning Transition in Times of Transition: Is There a Virtual Pathway from Pediatric to Adult Care?

    Ben Danna, Monique Maher, Miriah Gillispie-Taylor and Tiphanie Vogel, Baylor College of Medicine, Houston, TX

    Background/Purpose: The BRIDGE (Baylor Rheumatology Initiative: Developing and Guiding Engagement) program is a quality improvement initiative to develop a safe, comprehensive pathway for our patients…
  • Abstract Number: 1297 • ACR Convergence 2022

    A Paediatric-Adult Provider Dyad Care Model Improves Transition from Paediatric to Adult Health Care for Youth with Childhood-Onset Systemic Lupus Erythematosus

    Tala El Tal1, Abdulaziz el Mutairi1, Amanda Steiman2 and Earl Silverman3, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2Sinai Health System, Toronto, ON, Canada, 3The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multi-system autoimmune disease affecting 1 in 1000 individuals, of whom 20% develop the disease in childhood. Childhood-onset…
  • Abstract Number: 1299 • ACR Convergence 2022

    Hitting the Target Together: Supporting Shared Decision-Making with Juvenile Idiopathic Arthritis (JIA) Patients Followed in the Out-Patient Rheumatology Setting at the Hospital for Sick Children

    Jo-Anne Marcuz1, Brian Feldman2, Y. Ingrid Goh3, Niina Kim4, Piya Lahiry5, Deborah Levy2, Elizaveta Limenis6, Jeanine McColl7, Christine O'Brien8, Susan Paetkau4, Shirley Tse2, Kristi Whitney8 and Ronald Laxer2, 1Division of Rheumatology and Department of Rehabilitation, The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 2Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Division of Rheumatology, The Hospital for Sick Children; Department of Pediatrics, University of Toronto, Toronto, ON, Canada, 6Division of Rheumatology, The Hospital for Sick Children; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 8Division of Rheumatology and Department of Rehabilitation, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in children with significant morbidity that extends into adulthood. Despite advances in effective…
  • Abstract Number: 1295 • ACR Convergence 2022

    Targeting Barriers That Prevent Contraception Counseling in an Academic Rheumatology Practice

    Tara Skorupa1, Kristin Sturm2, Aaron Lazorwitz2, Guiset Carvajal Bedoya3, Ju Young Kwag2, JoAnn Zell2 and Kristen Demoruelle2, 1University of Colorado, Aurora, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3Billings Clinic, Billings, MT

    Background/Purpose: Systemic autoimmune diseases disproportionately affect females of childbearing potential. Many of the medications used to treat systemic autoimmune diseases have suspected or confirmed teratogenic…
  • Abstract Number: 1306 • ACR Convergence 2022

    Improving Osteoporosis Screening in Individuals of Color

    Megan Brochu1, Kristofer Marcus1, Sarah Latorre1, Francis Wanjau1, Arvin Garg2, Eric Alper2, Rulan Lyu1, Tracey Wilkie1 and Jonathan Cheah3, 1UMass Memorial Health, Worcester, MA, 2UMass Memorial Health, UMass Chan Medical School, Worcester, MA, 3UMass Chan Medical School, Worcester, MA

    Background/Purpose: Osteoporosis, including the clinical event of fragility fracture is an ever-increasing public health burden. Effective screening techniques and well as therapies to reduce future…
  • Abstract Number: 1305 • ACR Convergence 2022

    Characterizing Bone Microarchitecture with MRI in Patients with Systemic Lupus Erythematosus

    Joshua Novack1, Gregory Chang2, Stephen Honig1, Anmol Monga2, Xiaoliu Zhang3, Punam Saha3, Dimitri Martel2, Peter Izmirly4, H Michael Belmont5, Jill Buyon4 and Amit Saxena5, 1NYU Langone Health Department of Medicine, New York, NY, 2NYU Langone Health Department of Radiology, New York, NY, 3University of Iowa Departments of Radiology and Electrical and Computer Engineering, Iowa City, IA, 4NYU Grossman School of Medicine, New York, NY, 5NYU School of Medicine, New York, NY

    Background/Purpose: Fractures in patients with systemic lupus erythematosus (SLE) are more common than age and sex matched controls. Fracture risk is traditionally assessed by dual-energy…
  • Abstract Number: 1307 • ACR Convergence 2022

    Effect of Romosozumab in Postmenopausal Women with Knee Osteoarthritis: Results from the FRAME Clinical Trial

    Nancy Lane1, Donald Betah2, Cynthia Deignan2, Mary Oates2, Zhenxun Wang2, Jen Timoshenko3, Aliya Khan4 and Neil Binkley5, 1University of California Davis, Hillsborough, CA, 2Amgen, Inc., Thousand Oaks, CA, 3UCB Pharma, Slough, United Kingdom, 4McMaster University, Oakville, ON, Canada, 5University of Wisconsin, Madison, WI

    Background/Purpose: Osteoarthritis (OA) and osteoporosis (OP) often occur concomitantly in the elderly. The relationship between OA and OP is complex, with increased fracture risk reported…
  • Abstract Number: 1249 • ACR Convergence 2022

    Short-term Variations in Subchondral Tibial Bone Texture of Conventional X-Rays Predicts Knee Osteoarthritis Progression

    Ahmad Almhdie-Imjabbar1, Hechmi TOUMI2, Zineb ZERZOUF3 and Eric LESPESSAILLES4, 1University of Orleans / CHR Orleans, France, Orleans, Centre, France, 2Regional hospital centre of Orleans, France, Orleans, France, 3University of Tours, Tours, France, 4Regional hospital centre of Orleans, France, ORLEANS, Centre, France

    Background/Purpose: Early detection and assessment of Knee Osteoarthritis (KOA) prognostic factors are crucial for developing management and treatments that aim at prevention of irreversible damage…
  • Abstract Number: 1198 • ACR Convergence 2022

    Validation of Remote Physical Performance and Cognitive Functioning Measures Among Individuals with Systemic Lupus Erythematosus

    Courtney Hoge1, C. Barrett Bowling2, Charmayne Dunlop-Thomas1, Bradley Pearce1, S. Sam Lim1, Cristina Drenkard1 and Laura Plantinga1, 1Emory University, Atlanta, GA, 2Duke University, Durham, NC

    Background/Purpose: The disruption of the COVID-19 pandemic presented an opportunity for researchers to develop and administer remote versions of measures for ongoing studies. In an…
  • Abstract Number: 1054 • ACR Convergence 2022

    Distinct Differences in Complement Perturbation Between Scleroderma-related Interstitial Lung Disease with and Without Emphysema

    Claire Beesley1, Alice Cole2, Nina Goldman1, Odewale Oluwakorede1, Joseph Barnett2, David Abraham1, Chris Denton1, Rizgar Mageed3 and Voon Ong4, 1University College London, London, United Kingdom, 2Royal Free Hospital, London, United Kingdom, 3Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University, London, United Kingdom, 4UCL Medical School Royal Free Campus, London, United Kingdom

    Background/Purpose: Aberrant complement activation is associated with autoimmune diseases including systemic sclerosis (SSc). As a leading cause of death in SSc, interstitial lung disease (ILD)…
  • « Previous Page
  • 1
  • …
  • 567
  • 568
  • 569
  • 570
  • 571
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology